Is routine monitoring of hepatic and renal function beneficial following single-dose methotrexate treatment for ectopic pregnancy? A 4-year review of experience from a teaching hospital-Reference-Cited by-同舟云学术

Is routine monitoring of hepatic and renal function beneficial following single-dose methotrexate treatment for ectopic pregnancy? A 4-year review of experience from a teaching hospital

Published:2008-01 Issue:4 Volume:28 Page:434-435
ISSN:0144-3615
Container-title:Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Journal of Obstetrics and Gynaecology

Author:

Darbhamulla A.,Bhal K.,Lal S.

Publisher

Informa UK Limited

Subject

Obstetrics and Gynaecology

Link

http://www.tandfonline.com/doi/pdf/10.1080/01443610802163773

Reference5 articles.

1. Comparison of success rates in the medical management of ectopic pregnancy with single-dose and multiple-dose administration of methotrexate: a prospective, randomized clinical trial

2. Life-threatening neutropenia following methotrexate treatment of ectopic pregnancy: A report of two cases

3. A Cautionary Tale

4. A Rare Drug Reaction to Methotrexate After Treatment for Ectopic Pregnancy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidosing Intramuscular Administration of Methotrexate in Interstitial Pregnancy With Very High Levels of β-hCG: A Case Report and Review of the Literature;Frontiers in Endocrinology;2018-07-10

2. Evaluation of hepatic, renal and hematologic parameters during single, double and multiple treatment with Methotrexate in patients with ectopic pregnancy hospitalized in AL Zahra hospital;J RES MED DENT SCI;2017

3. Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF;European Journal of Obstetrics & Gynecology and Reproductive Biology;2016-10

4. Routine Monitoring of Liver, Renal, and Hematologic Tests After Single- or Double-Dose Methotrexate Treatment for Ectopic Pregnancies After In Vitro Fertilization;Journal of Minimally Invasive Gynecology;2015-11

5. États des lieux et expertise de l’usage hors AMM du méthotrexate en gynécologie–obstétrique : travail du CNGOF;La Revue Sage-Femme;2015-06